# AECC Innova

**Funder:** AECC
**TRL:** 6-9
**Frequency:** Annual
**Eligible countries:** ES
**Official call:** https://www.contraelcancer.es/es/area-investigador/ayudas/proyectos/aecc-innova-2026
**Last updated:** 13 Sept 2026

## Eligibility & scope

AECC 2026 call funding innovative, near-market translational cancer research projects in Spain.

## Summary

AECC Innova funds translational cancer research projects in Spain that are close to clinical or market application, spanning technology readiness levels 6 through 9. The 2026 call targets teams ready to move a cancer therapy, diagnostic, or intervention toward real-world use rather than early-stage discovery. AECC runs this call annually as part of its broader cancer research funding programme.

## Who should apply

- Research teams with cancer projects already validated at a proof-of-concept or later stage (TRL 6-9)
- Institutions and researchers based in Spain
- Projects focused on translational or applied cancer research rather than basic science
- Teams with a clear near-term path toward clinical or commercial application

## Key dates

- 2026 call cycle, part of AECC's annual funding programme
- Targets projects at TRL 6-9 (late-stage translational, near-market)

## Tips for applicants

- Frame the proposal around a clear path to clinical or commercial deployment, since TRL 6-9 scope means reviewers expect demonstrated feasibility, not exploratory science.
- Highlight any existing prototypes, pilot data, or regulatory groundwork already completed, as this call favors projects with a short runway to patients or market.
- Confirm all project partners and host institutions are based in Spain before applying, since eligibility is restricted to Spanish projects.

## Frequently asked questions

### What does AECC Innova fund?

It funds near-market translational cancer research projects at technology readiness levels 6 to 9, meaning work close to clinical or commercial application.

### Who is eligible for AECC Innova?

Researchers and institutions based in Spain working on translational cancer research are eligible to apply.

### Is AECC Innova a recurring call?

Yes, AECC runs this call annually, with the 2026 edition open for translational cancer projects.

### What TRL range does AECC Innova target?

Projects must sit within TRL 6-9, the late-stage development and near-market range rather than early discovery research.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/aecc-innova-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).